QUESTIONARY

muskrateurekaBiotechnology

Feb 12, 2013 (4 years and 2 months ago)

260 views


information of organization

Name of organization

Tel Aviv U
niversity

Main researchers and expertise

(name, surname, academic degree)

Dr. Nir Osherov. Lecturer. Fungal Molecular Biology


Organization type



x





Consultancy

Research

Education

Industry

Technology
Transfer





x


Non
-
Commercial

Other


SME

Owned by non
-
SME





Organization Size

(employees)



x

< 10


10
-
49



50
-
99



100
-
199


200
-
249


>250


Short description of organization

(main research activities)

My research group is studying

the following topics:

Aspergillus conidial germ
ination at the
molecular level

A
ntifungal compounds in vitro and in vivo, antifungal drug combinations and
antifungal resistance with an emphasis on Caspofungin

PROJECT DETAILS

Project type



x



IP

NoE

STREP

CA

Other:

Call info

(which call does the PS refer to?)

Control of anti
-
fungal drug resistance (especially orientated towards
involvement of SMEs)


STREP
LSH2004
-
2.12

Topic

Antifungal drug resistance

Title

Analysis and control
of antifungal drug resistance in Candida and Aspergillus
spp.

Description

(incl. budget outline)


We propose a genomics
-
based integrated approach to address anti
-
fungal
resistance through
:

D
evelopment of new therapeutic approaches,

using existing and nov
el drug
combinations, based on genomic screens and expression profiling.


E
luci
dating mechanisms of resistance to azoles and echinocandins in Candida
and Aspergillus.


V
alidating intervention strategies to minimise resistance

using the in vitro
results fro
m (1) and (2) in animal models for
systemic
candidiasis and

invasive

aspergillosis.

Partners involved




Target partner(s)

(type, expertise required and role in
the project)

Molecular biologist with expertise in drug resistance mechanisms in Candida
spp
.

M.D (infectious diseases) with an expertise in fungal infections, working
within a setting of a large teaching hospital.

Pharm.D with an expertise in antifungal drugs (in vitro testing, animal
models etc), working within a setting of a large teaching hos
pital.

Research group specializing in Aspergillus infections, genomics, proteomics
etc.



C
C
O
O
N
N
T
T
A
A
C
C
T
T


D
D
E
E
T
T
A
A
I
I
L
L
S
S

Name, Surname:

Dr. Nir Osherov

Address:

Department of Human Microbiology, Sackler School of
Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6997
8,
Israel

Phone:

972
-
3
-
640 9599

Fax:

972
-
3
-
640
-
9160

e
-
mail:

nosherov@post.tau.ac.il

Web site:




Partner Search


A1
: Principal Investigator’s contact details:


Name:
Bagatzounis Athanasios, MD

Contact Address:
BOC Oncology Centre, 32, Akropoleos Ave
nue, 2006 Strovolos, Cyprus


Telephone:
+357 22 841 350

Fax:
+ 357 22 841 345

Email:
thanasis.bagatzounis@bococ.org.cy

Web page:


A2
: Area (s) of Research interests:
Cancer


A3
: Topic code as des
cribed in work Program:
LSH
-
2004
-
2.2.0
-
9



September 2004


A4
: Description of the topic as it appears in the Work Program:

Feasibility study for the coordination of national cancer research activities






A5
: Proposed research project that could b
e in line with Work Program topic (max 10 lines):

Cancer is a major public health problem and reducing its burden is a challenging undertaking
that requires coordinated actions at a national and supranational level. A national strategic plan
against cancer

in Cyprus is currently under construction and coordination of research activities
is an integral part of it.

Objectives of the proposed project:

a) to systematically register current research activities in the field of cancer in Cyprus/Europe
and establis
h a forum for discussion of a research agenda for the future,

b) to accelerate the translation of existing research results into clinical applications by
disseminating evidence
-
based guidelines,

c) to address ethical and cultural aspects in cancer research
,

d) to exchange experience with researchers from other European countries.

TURKISH RESEARCHERS FOR L
IFE
S
CI
H
EALTH

(3th call)


In the following,

there is a list of some researchers

that
are enthusiastic about and willing

to

participate in

3th call

LifeSciH
ealth P
rojects.



NAME

TITLE

UNIVERSITY

AREA OF INTEREST

TOPIC REFERENCE FROM THIRD
CALL

E
-
MAIL

Salih Sanlioglu

Director,
VMD, PhD

The Human Gene Therapy Unit of
Akdeniz University Faculty of
Medicine

www.akdeniz.
edu.tr


Development of new therapeutic
methods for autoimmune diseases
such as Rheumatoid Arthritis and
Type I Diabetes as well as
generation of oncolytic viruses for
cancer virotherapy.



Functional genomics and
molecular markers for prevention of type 1
d
iabetes
-

INTEGRATED PROJECT



Post genomic approaches for the
development of prognostic indicators for
the control of inflammatory rheumatic
disease


INTEGRATED PROJECT.



Oncolytic virus vectors for cancer
virotherapy
(especially orientated towards
involvem
ent of SMEs)



STREP.


sanlioglu@ak
deniz.edu.tr

Cafer Eroglu

Associated
Professor

Ondokuz Mayis University School
of Medicine

Clinical Microbiology and
Infectious Diseases

www.omu.edu.tr


Molecular Diagnosis and
Epidemiology of Viral Hepatitis

Moleculer diagnosis of infectious
diseases

Antimicrobial resistance detection
and epidemiology

Epidemiology of diarrheal and
nosocomial infections



Rational and accelerated
deve
lopment of new, safer, more effective
drugs including pharmacogenomics
approaches



Development of new diagnostics



Combating resistance to
antibiotics and other drugs



Developing new promising
candidate vaccines and therapies

ceroglu@omu
.edu.tr

Aykut Kence

Prof. Dr.

Department of Biology,

Middle East Technical University

www.metu.edu.tr


Evolutionary Biology,
Conservation genetics

Determination and conservation of
genetic reso
uces in Turkey.

Honeybees, Wild goats, Mouflon
are among my recent interests



Population genetics,
Conservation of Genetic Resources.


aykut@metu.
edu.tr


Nesrin
Cobanog
lu

Dr (MD)
(PhD)

Baskent University Faculty o
f
Medicine

Medical Ethics and History
Department

Medical ethics, environmental
ethics



ethics


nesrin@baske
nt.edu.tr

www.baskent.edu.tr

Arif ATAK


Researcher
(Master of

science and
DSPU)

Atatürk Horticultural Central
Researh Institute

Department of Viticulture

www.arastirma
-
yalova.gov.tr

Horticultural plants genomic
researches, using molecular
markers, and production of
healthy plants



Fundemental Knowledge and
basic too
ls for functional genomics in all
organisms


arifatak@yah
oo.com


Fatima
YUCEL


Phd

TUBITAK
-
RIGEB
(Research
Institute for Genetic Engineering
and Biotechnology)

www.rigeb.gov.tr


the

production of monoclonal
antibodi
es with high specificity

against various plant pathogens
(bacteria and virus),

human
proteins and steroid hormones by
using the

advanced cell culture
techniques and the development of
immune diagnostic kits based on
monoclonal antibodies using
ELI
SA systems.

Together with the cell culture, cell
fusion techniques and ELISA ,
electrophoresis, immunblotting
and some of the chromatography
techniques for the purification and
characterization of monoclonal
antibodies and Anti
-
idiotypic
antibodies



Develo
pment of new diagnostics

(LIFESCIHEALTH
-
1.2.2)



Development of an HIV vaccine
(LSH
-
2002
-
2.3.0
-
1)

fatma@rigeb.
gov.tr


Ufuk Gunduz


Prof.Dr.
(Ph.D)

Middle East Technical University
,
Molecular Bıology and Genetics

www.metu.edu.tr

Molecular biology of Cancer



Tumor and host interactions


ufukg@metu.
edu
.tr


JULIDE
AKBUG
A


Prof Dr

Marmara Universitesi,

Pharmaceutical Technology

www.marmara.edu.tr

Peptid,protein formulation

Non viral gene delivery

New vaccines

Cell culture studies with
membranes

Wound healing




Developing new promising
candidate vaccines and therapeutics



New approaches for accelerated
devel
opment of new safe and more
effective medicines



Targetted delivery of protein
based drugs



Standardised assays for
determining immunogenicity of
biopharmaceuticals





jakbuga@hot
mail.com

Omer
Goktekin

Associate
Pr
ofessor

Osmangazi University, Faculty of
Medicine, Cardiology
D
epartment

www.ogu.edu.tr

Cardivascular disease



Combating, cardiovascular
disease, diabetes and rare diseases

g
oktekin@hot
mail.com

Nedret Kılıc

Prof Dr

Gazi University Faculty of
medecine, medical Biochemistry

www.gazi.edu.tr

Age related diseases and
prevention



Neuroimmune disorders from
basic to clinical research

nedretk@gazi
.edu.tr

Huveyda
Basaga


Prof

Sabanci University Biological
sciences and bioengineering

www.sabanciuniv.edu

Biochemistry, molecular biology



The intracellular routes of
polypeptide growth factor signalling
-

INTEGRATED PROJECT



Cell
systems as a means to
enhance toxicity testing
-

INTEGRATED
PROJECT



Chemokines: A new therapeutic
approach for chronic inflammation and
autoimmune diseases



INTEGRATED
PROJECT



Genomics of cardiomyocyte
signalling relevant to heart failure
-

INTEGRATED PRO
JECT
.




Functional and

proteomic
analysis of ageing
-

INTEGRATED
PROJECT



European research on ageing



SSA.



Coordination of activities in
poverty
-
related diseases between the
European biotech industry, bioincubators
and biotech investors


CA



1
-
day Conferen
ce on the state of
the art of stem cell research, focusing on
the potential and limitations for curing
severe diseases, aimed at patients


SSA



European human embryonic stem
cell registry


-

SSA


huveyda@sab
an
ciuniv.edu

Vasif Hasirci

Professor

METU Department of Biological
Sciences, Biotechnology Research
Unit

www.metu.edu.tr


Biomaterials with special
emphasis on nanotechnology and
Tissue engineering, Drug delivery
and

targeting, Smart systems



Targeted delivery of protein
-
based drugs (especially orientated towards
involvement of SMEs)
-

STREP.



Development of new non
-
viral
gene delivery technologies for ex vivo
gene
-
based therapies (especially orientated
towards involve
ment of SMEs)


STREP.



Human stem cells for spinal cord
injury repair


STREP.



Heart repair and cardiac plasticity
vhasirci@met
u.edu.tr


-

INTEGRATED PROJECT.



Exploring the potential of human
umbilical cord blood stem cells for
application other than allogeneic
haematopoietic t
ransplantations
-

STREP.



Promotion of cooperation with
Associated Candidate Countries (ACC)


Kutlu Ulgen

Professor

Department of Chemical
Engineering, Bogazici University

www.boun.edu.tr

Syst
em level understanding of the
cell and establishment of new
strategies for the rational design
through identification of target
sequences for the development of
new products and improved
processes in yeast and/or
mammalian cells using a system
biology app
roach.



Fundamental knowledge and
basic tools for functional genomics


ulgenk@boun
.edu.tr


Betul Kirdar

Prof. Dr.

Bogazici University, Faculty of
Engineering, Department of
Chemical Engineering

www.boun.edu.tr

Syst
em level understanding of the
cell and establishment of new
strategies for the rational design
through identification of target
sequences for the development of
new products and improved
processes in yeast and/or
mammalian cells using a system
biology app
roach.




Fundamental knowledge and
basic tools for functional genomics



kirdar@boun.
.edu.tr

Ali Osman
BELDUZ

Assoc.
Prof.

Karadeniz Technical University,
Dept. of Biology

www.ktu.edu.tr

Thermophilic Bacteria
Systematics,

Cloning and characterisation of
thermophilic enzymes

Protein:Ligand Interactions



Gene expression and proteomics
LSH
-
2004
-
1.1.1
-
* IP




Multidisciplinary functional
genomics approaches to basic biological
pr
ocesses LSH
-
2004
-
1.1.5
-
* IP or NoE


belduz@ktu.e
du.tr

ASUMAN
DEMIROGLU


ASST.PRO
F. DR

GEBZE INSTUTITE OF
TECHNOLOGY

DEPARTMENT OF BIOLOGY

MOLECULAR BIOLOGY
SECTION

www.gyte.edu.tr

Cell Signalling, Cancer, Protein

tirozin kinases, Molecular Cell
Biology





ademiroglu@
gyte.edu.tr


Murat
YILDIRIM


Kirikkale University, Faculty of
Veterinary Medicine, Department
Molecular diagnosis of zoonotic
infec
tions, Plasmid profil analysis



muratyildirim
@kku.edu.tr

of Microbiology

www.kku.edu.tr

of Staphylococcus spp,
Epidemiology of zoonotic
infections (Brucellosis,
Campylobacteriosis), Analysis of
genetic variability of animal
originated food
-
borne pathogens.,
Analysis and risk assessment of
agricultural use of ant
ibiotics on
human health. Epidemiology of
animal originated food
-
related
human diseases, Examine the
interraction of trace element and
immun potence of food animals


Neslihan
DIKM
ENOGL
U

Associate
Professor
of
Physiology,
M.D.

Hacettepe University School of
Medicine

Department of
Physiology

www.hacettepe.edu.tr

Hemorheology




ndikmen@ha
cettepe.edu.tr

Sedat
Kaygusuz


Ass. Prof.
Dr.

Ki
rikkale University, Faculty of
Medicine, Infectious Diseases and
Clinical Microbiology

www.kku.edu.tr

Molecular microbiology, virology,
bacteriology





skaygusuz@y
ahoo.com


YASAR
NAKIPOGLU

MICROBI
OLOGIST
DR

UNIVERSITY OF ISTANBUL,
FACULTUY OF MEDICINE,
DEPARTMENT OF
MICRIBIOLOGY AND
CLINICAL MICROBIOLOGY

www.istanbul.edu.tr

ANTIBIOTIC AND CHEMICAL
RESISTANCE IN THE
BACTERIA,

NOSOCOM
IAL INFECTIONS,
ENVIRONMENTAL
BACTERIAL
CONTAMINATION,
GLYCOPEPTIDE RESISTANCE
IN STAPHYLOCOCCI,
LEGIONELLA IN THE WATER
AND CLINICAL SPECIMENS





kirkuk@hotm
ail.com

Aziz Akin
Denizci


PhD

RIGEB
(Research Institut
e for
Genetic Engineering and
Biotechnology)

www.rigeb.gov.tr


the

isolation and identification of
micro organisms and the
production, purification, of
microbial enzymes.
Research on
screening, isolation and
identification of the micro
organisms having th
e anti
-
tumoral



denizci@rige
b.gov.tr

or anti
-
fungal activity from local
ecosystems are another interest of
my research.

Aynur Basalp


Assoc. Prof

TUBITAK / RIGEB

www.rigeb.gov.tr

1. Production of monoclonal
an
tibodies to various antigens
including plant pathogens, human
pathogens and various hormones
-
proteins by using hybridoma
technology and development of
ELISA based immunodiagnostics
kits.

2. Enhancement of immune
response to Hepatitis B vaccine by
monoclon
al antiboides.

3. Detection of Immune response
to various polymeric carriers.

4. Role of CD23 receptors on
Follicular Dendritic Cells in the
regulation of allergy.




basalp@rigeb.
gov.tr


Belma
Konuklugil



Univ.of Ankara,faculty of
Pharmacy

www.ankara.edu.tr

Phytochemical research on plant
species. I
solatıon and
ıdentıfıcatıon of secondary
metabolites, especially lignans and
plant cell culture studies.

Lıgnans,podophyllotoxin,
secondary metabolites from cell
cultures, essential oils.





B
elma.Konuk
lugil@pharma
cy.ankara.edu
.tr

H.BENAN
DINCTURK



ISTANBUL TECHNICAL
UNIVERSITY
-
DEPARTMENT
OF MOLECULAR BIOLOGY
AND GENETICS

www.itu.edu.tr

Expression and characterization of
the archaeal nitrogen metabolism
genes, specifically on glutamate
synth
ases of Methanococcus
jannaschii and Pyrococcus
horikoshii


Cloning of the microaerobic
metabolism enzymes in the
photosynthetic sulfur bacterium
Allochromatium vinosum

Recombinant protein expression,
archeal enzymes





dincturk@itu.
edu.tr


Berrin Erdag


Phd

TUBITAK
-
RIGEB

www.rigeb.gov.tr

production of recombinant
antibodies and peptides with high
specificity

against various targets
such as plant pathogens (bacteria
and

virus),

human proteins using
phage display technology.


-

Phage displayed
recombinant antibodies
and peptide libraries

-

DNA fingerprinting

-

Molecular Diagnosis of
genetic disease

-

Gene cloning, protein
expression and
purification


Biochemica
l and
molecular biological standard
procedures (e.g. ELISA enzyme
assays, Northern
-
, Southern
-
,
Western blotting, PCR, RT
-
PCR
and DNA sequencing)





berrin@rigeb.
gov.tr

Hulya
Zeytinoglu


Anadolu University
-
Facult
y of
Science
-
Dept. Of Biology

www.anadolu.edu.tr

Molecular Biology of cancer,
genotoxicity, animal cell culture,
cellular signaling





hzeytino
@ana
dolu.edu.tr


Abdul Rezzak
Memon


Prof.

TUBITAK, RIGEB

www.rigeb.go
v.tr

Foreign proteins and antibiotic
production in plants.

Protein targeting and secretion in
plant cells

Use of plants and algae for clean
up contaminated soils and waters

Molecular Biology, Cloning, Plant
Molecular Genetics, Molecular
Cell Biology





armemon@ri
geb.gov.tr

NAZIM
SERDAR
TURHAL


MARMARA UNIV MEDI
CAL
ONCOLOGY

www.marmara.edu.tr

Cancer care




turhal@super
online.
com

Sevnur
Mandacı

PhD

TUBITAK RIGEB

www.rigeb.gov.tr

Molecular Bioenergetics
Laboratory in Research Institute
for Genetic Engineering and



sevnur@rigeb
.gov.tr

Biotechnology (RIGEB) focuses
on cytochromes of photosynthetic
bacteria.

A
s Research Activity:

Project

1: Molecular Structure and
Functions of Cytochromes in
Rhodobacter capsulatus.
TUBİTAKy supported: in 1996
-
2000
.


Project

2: Novel electron carries in
Rhodobacter

species,

ICGEB
supported, CRP/TUR99
-
01, in
2000
-
2003.


Project 3
: Investigations on Novel
Type Cytochrome cbb
3

Oxidase
Genes and Proteins in Model
Bacteria,

TUBITAK

TBAG
-
supported in 2001
-
2004.


And interested in biohydrogen
production.

E.SUMER
ARAS



An
kara University, Science
Faculty, Department of Biology,

Biotechnology Section

www.ankara.edu.tr

Molecular Biology




aras@science.
ankara.edu.tr


Partner Search


A1
: Principal Investigator’s contact details:


Name:
K. KYRIACOU

Contact Address:
The Cyprus
Institute of Neurology and Genetics

Telephone:
00357
-
22392631

Fax:
00357
-
22392641

Email:
kyriacos@cing.ac.cy

Web page:
http://www.cing.ac.cy


A2
: Area (s) of Research intere
sts:
Cancer


A3
: Topic code as described in work Program:
see below




Deadline:
November 2004


A4
: Description of the topic as it appears in the Work Program:

LSH
-
2004
-
2.2.0
-
4: Prevention of cancer in high risk populations
-
NETWORK OF EXCELLENCE.


LSH
-
2004
-
2.2.0
-
6: Prevention, detection and treatment of familial cancers, such as cancer of the prostate,
ovary, breast, colon and skin
-
STREP.


LSH
-
2004
-
2.2.0
-
8: Tumour
-
host interactions
-
STREP.




A5
: Proposed research project that could be in line with
Work Program topic (max 10 lines):

LSH
-
2004
-
2.2.0
-
4: The discovery of cancer predisposition genes enables the pre
-
symptomatic diagnosis of
common hereditary cancers such as colon, breast, ovary and prostate. At the European level, however, great
difference
s exist in the recruitment, management and treatment of these patients/individuals. These need to be
addressed at a European level in order to produce standardized
protocols
and uniform therapies across Europe.


LSH
-
2004
-
2.2.0
-
8: Breast cancer is the commo
nest malignancy of the European female population.
Among the different histopathological types DCIS presents one of the earliest lesions. Current molecular
data support the view that DCIS progresses to invasive cancer, which entails more aggressive treatme
nts
and a poorer prognosis. There is a need to improve our understanding of the epithelial
-
stromal
interactions that take place in the progression of DCIS to invasive breast carcinoma.


We have recently started to prepare a specific targeted research proj
ect (STREP) targeting the
following line:


Development of new non
-
viral gene delivery technologies for ex vivo gene
-
based
therapies (especially orientated towards involvement of SMEs). The objective of this
project is to apply ex vivo gene therapies to dis
eases with high unmet medical need. It
should mobilise industrial and academic know
-
how to develop new and efficient
technologies for non
-
viral gene delivery which will circumvent the toxicity and
immunogenicity problems raised by viral delivery systems.


Project title : EX VIVO GENE
-
BASED IMMUNOTHERAPY FOR AUTOIMMUNE
DISEASE : GENETIC ANTIGEN
-
PRESENTING CELL MANIPULATION FOR
INDUCTION OF TOLERANCE IN RHEUMATOID ARTHRITIS


The aim of the project would be the development a high throughput screening technolog
y for
ex vivo transfection of APCs with siRNA specific for genes implicated in immune response,
and compare their performances with ex vivo viral gene transfert of siRNA. The DC
phenotype, antigen presentation capacity and tolerogenic effects will be monit
ored in vitro.
Then, vaccination strategies using antigen
-
pulsed and genetically modified DC will be
evaluated in vivo for induction of an antigen
-
specific peripheric tolerance in an experimental
model for rheumatoid arthritis. DC will be use as cellular v
ehicules for gene therapy : they
will be genetically modified ex vivo and reintroduced into the body with the hope that a
proportion will home to the diseased tissue.


Do you have a list of companies/academics that can be interested in this project?If not
, can
you disseminate this email?
The project would be coordinated by Florence Apparailly
from INSERM

(French National Institute for Medical Research) who is located in
Montpellier, France.



Dahlia FASQUEL


___________________________


Dahlia Fasquel

Ins
erm Transfert

Assistant Project Manager

CHU Lapeyronie

Unité d'Immuno
-
Rhumatologie

34 295 Montpellier Cedex 5

Tel :00 33 (0)4 67 54 43 57

Mobile :00 33 (0)6 79 42 43 68

Fax :00 33 (0)4 67 33 77 98


Privately held biotech company active in the d
iscovery and development
of drugs to treat metabolic diseases, such as type 2 diabetes and
obesity, and is active in process development and contract
manufacturing of protein therapeutics. The company has strong
intellectual property and technology platfor
ms, with a number of
compounds in pre
-
clinical and clinical development. It is one of the
largest biotech companies in Europe with more than 550 employees.
Annual revenues, including royalties and contract service fees, finance a
major part of the annual r
esearch budget.

TURKISH SMEs


Below you can find

a list of some Turkish SMEs

that are ready to participate in the

3th call
-
LifeSciHealth Projects


SME

Number of
employees

Expertise

Description

Website


Contact Person


E
-
mail

YASAM
BANKASI


25


st
em cell

Cord Blood

Gene Therapy

Expantion cells


General objectives of
this company are:
1)cryopreservation of
umblical cord blood
2)Participating and
coordinating stem
cell researches

www.kordonkani
bankasi.com

SEDA GELİR
MD

sedagelir@kordonkanibankasi.co
m

RTA
LABORATORIES


30

Molecular

biotechnology

microbiology

vaccine

in vitro
diagnostics

IVDD



Based upon
microbiology our
company is interested
in researches and
developments in
biotechnology


ALI

TAS, DVM,
PhD


rtalabs@rtalabs.com.tr


Ortopro
Orthopedic
Implants A.S.


45


Biocompatible
coatings

Biomaterials

Bone substitutes

Surgical
Instruments

Orthopedic
Implants


Producer and
distributor of
orthopedic implants
and prosthesis,
mainly
internal/e
xternal
fixation, arthroplasty
products, spinal
system.


www.ortopro.co
m.tr


Nükhet Tercan


info@ortopro.com.tr


KURTSAN
PHARMACEUTI
CALS INC.

185


FUNCTIONAL
FOODS

EXTRUDED
PRODUCTS

HERBAL
Kurtsan
Pharmaceuticals Inc.
specializes in the
developm
ent and
production of modern
medicines, well
-
www.kurtsan.co
m


MS. AYLIN
KURT ONUR


kurtsan@kurtsan
.com


PRODUCTS


known Otaci brand
named natural/herbal
products and dietary
foods. Kurtsan
Pharmaceuticals Inc.,
founded in 1955 with
the main purpose of
combining traditional
medication methods
with modern
technology, owning
t
o the belief about the
healing power of
nature and steady
studies in this area, it
is the leading
manufacturer for
natural products in
Turkey and proud to
be filling consumer
satisfaction for 45
years.


BAHADIR

140

Surgical
instruments

Sterilisation,
forgings ,
containers,
hospital clogs

Manufacturing
company

www.bahadir.co
m

Murat Bahadir

murat@bahadir.com

SASAN

100

Medical

Hemodialysis

Cardiovascular

Surgery


Former
participation in a
project; CVP
Catheter
production

www.sasan.com.
tr

Mustafa Sayın

sasan@sasan.com.tr


Medikon AS S
TI


distributing Spinal
implants all over
the Turkey for last
10 years.

Most of the
implants are made
of Titanium
With the help of 10
years experience
and knowledge,
company

has

been
planning to design

and

sale their own
manufactured

Mr.Ugur
Tabuktekin

ugur@medikon.net


material and a few
implants are made
of PEEK
material


implants in spinal
& orthopedics line.



INTERFARMA AS



Medical and
surgical products
(surgical suture
materials, wound
management and
burns
treatment
products,
sterilization and
disinfectant
products, trauma
products,
mammary and
facial implants,
voice controlled
robotic arm and
Zeus systems,
Jobskin burns
garments and
liposuction device
and pressure
garments,
mammary
supports)


Turkish market

through a central
management
Office, 4regional
divisions and an
extensive network
of sub
-
distributors
(totally 110)

Has the ISO
Certificate and
CE mark



Mrs.Suna OK

Sales Director

sunao@interfarma.com.tr


MED
ISPO
MEDIKAL
TEKNIK SAN TIC
LTD STI


Design and
manufacture of
medical devices and
disposable products,
Biomedical
instrumentation, low
noise high gain
preamplifier design
and implementation,
microprocessor
based control and
test systems,


Mr.
Haldun Ozdemir

medispo@kosgeb.tekmer.gov.tr

microprocessor an
d
PC based data
acquisition and
processing systems,
design and
implementation of
electromechanics
systems, plastic
injection moulds.